29 (PB017): A novel small molecule activator of the integrated stress response kinase GCN2 shows potent preclinical antitumor activity as monotherapy and in combination with standard of care agents
Titel:
29 (PB017): A novel small molecule activator of the integrated stress response kinase GCN2 shows potent preclinical antitumor activity as monotherapy and in combination with standard of care agents
Auteur:
Al-Ani, G. Groer, Q. Eliott, K.M. Rudeen, A.J. Zwicker, J.D. Javed, S. Hood, M.M. Dhanak, D. Flynn, D.L. Smith, B.D.